Withings
Withings raises $60M Series B at $300M valuation
Quick Facts
Withings: Series B Funding Round
Withings has successfully raised $60M in Series B funding, reaching a valuation of $300M.
Company Overview
Connected health devices
Funding Details
The Series B round was led by Bpifrance, with participation from Idinvest Partners.
Company Information
- Headquarters: Issy-les-Moulineaux, France
- Founded: 2008
- Employees: 200+
- Category: HealthTech
Investment
Withings plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Bpifrance: Verified investor in Series B
- Idinvest Partners: Verified investor in Series B
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
